Search Results

The Why and the How of Adopting Interventional Glaucoma

The emerging data suggest a strong rationale for moving toward a glaucoma treatment paradigm in which procedures are favored early in the disease course.

Christine M. Funke, MD

IJC Recap: Pharmaceutical Management of Presbyopia, Lens-based Refractive Surgery, and a Protocol for Interventional Glaucoma

Inder Paul Singh, MD; Marjan Farid, MD; William F. Wiley, MD; and Christine M. Funke, MD

Seen & Heard

Cover Focus

Intraoperative Pearls for Stent Success

Keys to proper visualization and device placement.

Christine M. Funke, MD

Canaloplasty: How it Works and Where it Fits in the MIGS Armamentarium

An expert panel discussion on the role of canaloplasty for the management of glaucoma.

Analisa Arosemena, MD; Rachel G. Simpson, MD; Sahar Bedrood, MD, PhD; Larissa Camejo, MD; Christine M. Funke, MD; Shivani Kamat, MD; and Mary Qiu, MD

Standalone MIGS: What Are You Waiting For?

The OMNI^® Surgical System enables surgeons to perform a comprehensive, implant-free procedure that can be used to treat mild to moderate glaucoma.

Christine M. Funke, MD; Douglas McGraw, DO; and Jai G. Parekh, MD, MBA, FAAO

Insertion Pearls for The HYDRUS Microstent

Matt Schlenker, MD, MSc; Christine M. Funke, MD; and Lauren S. Blieden, MD

Insertion Confidence and the Schlemm’s Canal Dilation Potential of Two Different Trabecular Meshwork Implants: What Do the Published Data Tell Us?

Christine M. Funke, MD